Contrast Media Market Is Expected to Grow Significantly owing to the Increasing Number of Scanning Procedures.

As demonstrated by Precision Business Insights (PBI), the latest report, Contrast Media Market was valued at USD 6,536.1 million in 2023, growing at 6.8% CAGR during the forecast period 2024 to 2030. The key drivers of the extension of the global Contrast Media are rising demand for contrast CTs, venography, angiography and technology advancement in health care infrastructure, clear mucosal details, Increasing Research & Development activities and FDA Approvals, Growing prevalence of Chronic Diseases.

View The Detailed Report Description Here - https://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market

THE CONTRAST MEDIA MARKET DETAILED SEGMENTATION:
Based on the product type, the market is segmented into the following:
• Iohexol
• Iopamidol
• Iodixanol
• Iopromide
• Ioversol
• Iomeprol
• Gadoteric Acid
• Gadobutrol
• Gadoxetic Acid
• Definity
• Optison
• SonoVue/Lumason

Based on the Technology, the market is segmented into the following:
• X-Ray/CT
• MRI
• Ultrasound

X-rays/ CT Scan is expected to Dominate the Global Contrast Media market:
Based on the technology, the global contrast media is segmented into X-Ray/ CT Scan, MRI, and Ultrasound. Among these X-Rays is anticipated to account large revenue share in the forecast period globally. CT Scan is an X-ray image using a form of tomography I which a computer controls the motion of the X-ray source and detectors, processes the data, and produces the imaging. Furthermore, The X-ray/ Ct scan procedures are increasing rapidly y-o-y around the globe owing to an increase in the demand for precise disease diagnosis of chronic diseases. x-rays are considered the most critical diagnostic tool, particularly for lung cancer and traumatic brain injuries. The prevalence of these diseases is boosting the CT scan market's growth. Other market drivers are the increasing geriatric population, rising chronic diseases, fluctuating medical care toward image-guided interventions, and technological advancements in healthcare infrastructure. As per the report publicized by the American College of Chest Physicians in July 2020, lung cancer is one of the most commonly diagnosed tumours. It accounts for 11.8% of the total cancer cases globally. Worldwide lung cancer occurrences are predicted to rise by 39%, to 2.98 million, by 2030. An X-rays produces 3D images of skeletons and assistances in better diagnosis and surgeries for orthopaedics. Consequently, with the increasing burden of orthopaedic conditions, the stipulation for CT scanners is also anticipated to grow, which in turn is anticipated to drive the Contrast media in the forecast period.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=17188

Based on the geography the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Asia Pacific Global Contrast Media Market:
The Asia Pacific market is expected to increase in the global contrast media market over the forecast period. The Asia Pacific market is expanding as a result, the increasing prevalence of cardiovascular diseases, neurological diseases, and GIT problems leading to rise the contrast media market in the forecast period. Moreover, Asia Pacific contrast media market was valued at 2,305.1 million in 2022 and is expected to grow at 6.6% over the forecast years to reach USD 3,601.2 million by 2030. China is the leading country in the Asia Pacific region and the country alone contributed approximately 65% of APAC revenue. furthermore, the increasing prevalence of complex comorbidities and long-term health issues has led to a rise in diagnostic imaging tests like ultrasound, X-rays, and radical imaging technologies like MRI and CTs. In August 2022, gadopclenol, an MRI contrast agent with high relativity and less gadolinium dosage for adults and pediatric patients two years of age and up, was sanctioned by the US food and drug administration. A macrocyclic GBCA called gadopiclenol aids identify abrasions in the brain, spine, abdomen and other parts of the body that have peculiar vascularity

Request Methodology: https://www.precisionbusinessinsights.com/request-methodology/?product_id=17188

STRATEGIC NEW PRODUCT LAUNCHES, MERGERS, ACQUISITIONS, AND CONCURRENCE ARE THE KEY TACTICS ADOPTED BY MARKET PLAYERS:
In the recent research the Global Contrast Media market further divulge that the key players are intensively adopting strategies such as the launch of novel techniques and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In June 2023, Bayer, a global leader in radiology, initiated the Phase III clinical development program called QUANTI, aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). Gadoquatrane is a highly stable MRI contrast agent featuring high relaxivity being studied to evaluate the potential of a substantially lower gadolinium (Gd) dose for patients.

Key players in the global contrast media market are Jodas Expoim Pvt. Ltd., GE HealthCare, Unijules Life Sciences Ltd., JB Pharma, Bracco, Lantheus, Sanochemia Pharmazeutika GmbH, TAEJOON Pharmaceutical Co., Ltd., Guerbet, Bayer AG, Spago Nanomedical AB, M. Biotech Limited, Fuji Pharma Co., Ltd., Trivitron Healthcare, Subhra Pharma, Beijing Beilu Pharmaceuticals Co. Ltd., and Jiangsu Hengrui Pharmaceutical Co., Ltd.,

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.